Regulatory TEVAR clinical trials

被引:6
|
作者
Garcia-Toca, Manuel [1 ]
Eskandari, Mark K. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Div Vasc Surg, Chicago, IL 60611 USA
关键词
THORACIC AORTIC-ANEURYSMS; ENDOVASCULAR TREATMENT; REPAIR; GRAFT;
D O I
10.1016/j.jvs.2010.06.140
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:22S / 25S
页数:4
相关论文
共 50 条
  • [1] REGULATORY AUTHORIZATION OF CLINICAL-TRIALS
    SNELL, ES
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (06) : 625 - 627
  • [2] Regulatory issues for clinical trials in humans
    Collins, JF
    Sather, MR
    EPIDEMIOLOGIC REVIEWS, 2002, 24 (01) : 59 - 66
  • [3] Regulatory issues in ALS clinical trials
    Bryan, WW
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2004, 5 : 36 - 41
  • [4] Global regulatory requirements for xenotransplantation clinical trials*
    Noel, Luc
    XENOTRANSPLANTATION, 2012, 19 (02) : 71 - 71
  • [5] Clinical trials and evolving regulatory science in India
    Gupta, Y. K.
    Kumar, B. Dinesh
    INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (06) : 575 - 576
  • [6] A regulatory perspective on the setup of decentralised clinical trials
    Martin, Chloe
    Liu, Jia
    Cosman, Rasha
    Cohen, Jordan
    Joshua, Anthony
    Kent, Robert
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 161 - 162
  • [7] Regulatory issues for clinical gene therapy trials
    Cornetta, K
    Smith, FO
    HUMAN GENE THERAPY, 2002, 13 (10) : 1143 - 1149
  • [8] Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
    Furfaro, Lucy L.
    Payne, Matthew S.
    Chang, Barbara J.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8
  • [9] The Evolving Regulatory Landscape for Clinical Trials in India
    Barnes, Mark
    Flaherty, Jamie
    Caron, Minal
    Naqvee, Alishan
    Bierer, Barbara
    FOOD AND DRUG LAW JOURNAL, 2018, 73 (04) : 601 - 623
  • [10] Regulatory developments in the conduct of clinical trials in India
    Chaudhury, R. Roy
    Mehta, D.
    GLOBAL HEALTH EPIDEMIOLOGY AND GENOMICS, 2016, 1